Process Development and Scale-Up of a Novel Atypical DAT Inhibitor (S)‑CE-123

Documenti analoghi

• Chirality Matters: Fine-Tuning of Novel Monoamine Reuptake Inhibitors Selectivity through Manipulation of Stereochemistry
  di: Predrag Kalaba, et al.
  Pubblicazione: (2023-09-01)
• Modafinil-Induced Increases in Brain Dopamine Levels
  di: J Gordon Millichap
  Pubblicazione: (2009-04-01)
• Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors
  di: Melinda Hersey, et al.
  Pubblicazione: (2023-07-01)
• A Novel and Selective Dopamine Transporter Inhibitor, <i>(S)</i>-MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions
  di: Shima Kouhnavardi, et al.
  Pubblicazione: (2022-06-01)
• Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA
  di: Aurora Musa, et al.
  Pubblicazione: (2020-12-01)